GlassScriptPhysician profile
Mildred P Warren
NPI 1083935928
$3,734.03
in general payments reported to CMS, 2019-2025
22 companies · $449 in 2025
The $449 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $206 · 2021: $271 · 2022: $698 · 2023: $944 · 2024: $862 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,165 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,165.17 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $970.68 | 2019-2025 | Skyrizi, Botox, Rinvoq |
| Sun Pharmaceutical Industries INC. | $455.43 | 2019-2025 | Winlevi, Absorica Ld, Ilumya |
| Janssen Biotech, INC. | $435.53 | 2020-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $419.35 | 2021-2025 | |
| Leo Pharma INC. | $333.88 | 2021-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $188.12 | 2022-2025 | Dupixent |
| Pfizer INC. | $171.85 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $155.37 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $106.38 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $106.12 | 2021-2024 | Bimzelx, Cimzia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.29 | 2023-2024 | Spevigo |
| Allergan, INC. | $49.70 | 2019-2022 | |
| Genzyme Corporation | $49.16 | 2025 | |
| Organon LLC | $49.15 | 2025 | |
| Amgen INC. | $40.52 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $23.52 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.98 | 2022 | |
| Incyte Corporation | $22.47 | 2022 | |
| Biofrontera INC. | $19.04 | 2022 | |
| Verrica Pharmaceuticals INC. | $17.07 | 2024 | Ycanth |
| Dusa Pharmaceuticals, INC. | $16.81 | 2019 | |
| Almirall LLC | $14.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mildred Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.